Predicting Hemolytic Uremic Syndrome and Renal Replacement Therapy in Shiga Toxin-producing Escherichia coli-infected Children.

McKee RS, Schnadower D, Tarr PI, Xie J, Finkelstein Y, Desai N, Lane RD, Bergmann KR, Kaplan RL, Hariharan S, Cruz AT, Cohen DM, Dixon A, Ramgopal S, Rominger A, Powell EC, Kilgar J, Michelson KA, Beer D, Bitzan M, Pruitt CM, Yen K, Meckler GD, Plint AC, Bradin S, Abramo TJ, Gouin S, Kam AJ, Schuh A, Balamuth F, Hunley TE, Kanegaye JT, Jones NE, Avva U, Porter R, Fein DM, Louie JP, Freedman SB, Pediatric Emergency Medicine Collaborative Research Committee and Pediatric Emergency Research Canada
Clin Infect Dis. 2020 70 (8): 1643-1651

PMID: 31125419 · PMCID: PMC7931832 · DOI:10.1093/cid/ciz432

MeSH Terms (10)

Adolescent Child Cohort Studies Diarrhea Escherichia coli Infections Female Hemolytic-Uremic Syndrome Humans Renal Replacement Therapy Shiga-Toxigenic Escherichia coli

Connections (1)

This publication is referenced by other Labnodes entities:

Links